Yamada S - Search Results

1

Proposal of the Coagulation Score as a Predictor for Short-Term and Long-Term Outcomes of Patients with Resectable Gastric Cancer.

Kanda M, Tanaka C, Kobayashi D, Mizuno A, Tanaka Y, Takami H, Iwata N, Hayashi M, Niwa Y, Yamada S, Fujii T, Sugimoto H, Murotani K, Fujiwara M, Kodera Y. Kanda M, et al. Among authors: yamada s. Ann Surg Oncol. 2017 Feb;24(2):502-509. doi: 10.1245/s10434-016-5544-1. Epub 2016 Sep 6. Ann Surg Oncol. 2017. PMID: 27600621

2

Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma.

Yamada S, Nomoto S, Fujii T, Kaneko T, Takeda S, Inoue S, Kanazumi N, Nakao A. Yamada S, et al. Eur J Surg Oncol. 2006 Apr;32(3):303-7. doi: 10.1016/j.ejso.2006.01.002. Epub 2006 Feb 14. Eur J Surg Oncol. 2006. PMID: 16478656

3

A proposal of an appropriate surgical approach for cancer of the ampulla of Vater: retrospective analysis of 73 resected cases.

Yamada S, Fujii T, Sugimoto H, Takeda S, Inoue S, Nomoto S, Kanazumi N, Nakao A. Yamada S, et al. Hepatogastroenterology. 2007 Jan-Feb;54(73):10-4. Hepatogastroenterology. 2007. PMID: 17419221

4

Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis.

Yamada S, Takeda S, Fujii T, Nomoto S, Kanazumi N, Sugimoto H, Kasuya H, Kodera Y, Nagasaka T, Morita S, Nakao A. Yamada S, et al. Ann Surg. 2007 Aug;246(2):254-8. doi: 10.1097/01.sla.0000261596.43439.92. Ann Surg. 2007. PMID: 17667504 Free PMC article.

5

Frequent promoter methylation of M-cadherin in hepatocellular carcinoma is associated with poor prognosis.

Yamada S, Nomoto S, Fujii T, Takeda S, Kanazumi N, Sugimoto H, Nakao A. Yamada S, et al. Anticancer Res. 2007 Jul-Aug;27(4B):2269-74. Anticancer Res. 2007. PMID: 17695513 Free article.

6

Pancreatic cancer with paraaortic lymph node metastasis: a contraindication for radical surgery?

Yamada S, Nakao A, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Kodera Y, Takeda S. Yamada S, et al. Pancreas. 2009 Jan;38(1):e13-7. doi: 10.1097/MPA.0b013e3181889e2d. Pancreas. 2009. PMID: 18797422

7

The tumor suppressor NPRL2 in hepatocellular carcinoma plays an important role in progression and can be served as an independent prognostic factor.

Otani S, Takeda S, Yamada S, Sakakima Y, Sugimoto H, Nomoto S, Kasuya H, Kanazumi N, Nagasaka T, Nakao A. Otani S, et al. Among authors: yamada s. J Surg Oncol. 2009 Oct 1;100(5):358-63. doi: 10.1002/jso.21241. J Surg Oncol. 2009. PMID: 19274676

8

Nonfunctioning neuroendocrine pancreatic tumors: our experience and management.

Nomura N, Fujii T, Kanazumi N, Takeda S, Nomoto S, Kasuya H, Sugimoto H, Yamada S, Nakao A. Nomura N, et al. Among authors: yamada s. J Hepatobiliary Pancreat Surg. 2009;16(5):639-47. doi: 10.1007/s00534-009-0099-1. Epub 2009 Apr 14. J Hepatobiliary Pancreat Surg. 2009. PMID: 19365596

9

Pancreatic cancer with distant metastases: a contraindication for radical surgery?

Yamada S, Fujii T, Sugimoto H, Kanazumi N, Kasuya H, Nomoto S, Takeda S, Kodera Y, Nakao A. Yamada S, et al. Hepatogastroenterology. 2009 May-Jun;56(91-92):881-5. Hepatogastroenterology. 2009. PMID: 19621722

10

Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: influence of resection margin status on survival.

Kato K, Yamada S, Sugimoto H, Kanazumi N, Nomoto S, Takeda S, Kodera Y, Morita S, Nakao A. Kato K, et al. Among authors: yamada s. Pancreas. 2009 Aug;38(6):605-12. doi: 10.1097/MPA.0b013e3181a4891d. Pancreas. 2009. PMID: 19629002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,533 results

Search Page

Filters